Mobile Optical Diagnostics: Ending the Multibillion-Dollar Emergency Vertigo Workup
Dr. Dereck Mush, MD, MBA
Brainomix
AI software designed to optimize treatment decision-making for stroke patients.
What they do
The company creates automated imaging software that analyzes CT and MRI brain scans to help doctors diagnose and make treatment decisions for stroke and lung diseases. Stroke networks and healthcare systems buy their platform to coordinate urgent care.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Clinical AI triage
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Oxford, United Kingdom
- Region
- Europe
- Founded
- 2010
- Total funding
- $21M raised
Notable investors: Boehringer Ingelheim Venture Fund, Parkwalk Advisors, Tencent Holdings, Oxford University Innovation.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
De Novo AI in the Acute Care Pathway: How Queen of Hearts Redefines Emergency Triage Economics and Cath Lab Utilization
Dr. Dereck Mush, MD, MBA
Decentralizing the Neuro-ICU: The Clinical Economics of Quantitative Bedside Brain Monitoring
Dr. Dereck Mush, MD, MBA
The MCED Inflection Point: What Galleri's FDA Panel Backing Means for Cancer Screening
Dr. Dereck Mush, MD, MBA